ACE-536-B-THAL-002 - A Phase 2, double-blind, randomized, placebo-controlled, multicenter study to determine the efficacy and safety of luspatercept (ACE-536) versus placebo in adults with non transfusion dependent beta-Thalass

Project: Research project

Project Details

StatusActive
Effective start/end date3/1/188/31/50

Funding

  • Celgene Corporation
  • Celgene Corporation